key: cord-0013708-rcl5w847
authors: Lu, Chih-Hao; Yeh, Da-Wei; Lai, Chao-Yang; Liu, Yi-Ling; Huang, Li-Rung; Lee, Alan Yueh-Luen; Jin, S. -L. Catherine; Chuang, Tsung-Hsien
title: Correction: USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation
date: 2019-05-30
journal: Oncogene
DOI: 10.1038/s41388-019-0831-5
sha: f5802b51c0874b084e6e9386a347476370e8413f
doc_id: 13708
cord_uid: rcl5w847

nan

Following the publication of this article, the authors have noticed errors in Fig. 1a , b that were caused due to combined and accidental placement of unrelated data obtained from database search. The authors have corrected these figures. The amended version of Fig. 1 is shown below. Accordingly, the fifth sentence in the first subsection of the Results section is corrected as "Survival analysis of lung cancer data in cBioPortal using an online Kaplan-Meier analysis software revealed that patients with lung cancer exhibiting the top 9.2% high USP17 expression have a significantly lower survival rate than that of patients with a lower USP17 expression (Fig. 1b) ." This correction does not affect the conclusions depicted in Fig. 1a regarding high USP17 expression in lung cancers and those depicted in Fig. 1b for the correlation between high USP17 expression and lower survival rate of patients with lung cancer. These conclusions are also supported by other published data [1] [2] [3] and our experimental data shown in Fig. 1c , wherein the analysis of USP17 expression in the cDNA array of lung cancers by RT-qPCR demonstrated high expression of USP17 in lung cancers, in particular lung cancers at high stages. The high expression and the pro-tumoral effect of USP17 (DUB3/USP17L2) have also been reported for other tumor types [4-7]. The authors express their sincere apologies for these errors and any inconvenience caused.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. Table 1 . Data represent mean ± standard deviation of three analysis, *P < 0.05; **P < 0.01

The deubiquitinating enzyme USP17 is associated with nonsmall cell lung cancer (NSCLC) recurrence and metastasis

The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function

Deubiquitinase DUB3 regulates cell cycle progression via stabilizing cyclin A for proliferation of non-small cell lung cancer cells